Supplemental material
Human Vaccines & Immunotherapeutics
Volume 15, 2019 - Issue 5
Research Paper
Enhanced passive surveillance of influenza vaccination in England, 2016−2017– an observational study using an adverse events reporting card
Simon de LusignanDepartment of Clinical & Experimental Medicine, University of Surrey, Guildford, UKCorrespondence[email protected]
https://orcid.org/0000-0002-8553-2641View further author information
https://orcid.org/0000-0002-8553-2641View further author information, Filipa FerreiraDepartment of Clinical & Experimental Medicine, University of Surrey, Guildford, UKhttps://orcid.org/0000-0002-7717-8486View further author information
https://orcid.org/0000-0002-7717-8486View further author information, Silvia DamasoBiostatistics EPI, GSK, Wavre, Belgiumhttps://orcid.org/0000-0003-4851-4396View further author information
https://orcid.org/0000-0003-4851-4396View further author information, Rachel ByfordDepartment of Clinical & Experimental Medicine, University of Surrey, Guildford, UKhttps://orcid.org/0000-0002-4792-8995View further author information
https://orcid.org/0000-0002-4792-8995View further author information, Sameera PathirannehelageDepartment of Clinical & Experimental Medicine, University of Surrey, Guildford, UKhttps://orcid.org/0000-0002-5112-8296View further author information
https://orcid.org/0000-0002-5112-8296View further author information, Anne YeakeyClinical Safety & Pharmacovigilance, GSK, Rockville, MD, USAhttps://orcid.org/0000-0003-3691-3445View further author information
https://orcid.org/0000-0003-3691-3445View further author information, Ivelina YonovaDepartment of Clinical & Experimental Medicine, University of Surrey, Guildford, UKhttps://orcid.org/0000-0003-4856-3075View further author information
https://orcid.org/0000-0003-4856-3075View further author information, Anne SchuindClinical R&D, GSK, Rockville, MD, USAhttps://orcid.org/0000-0003-3544-0682View further author information
https://orcid.org/0000-0003-3544-0682View further author information & Gael Dos SantosClinical R&D, GSK, Wavre, Belgiumhttps://orcid.org/0000-0001-8623-3478View further author information
https://orcid.org/0000-0001-8623-3478View further author information show allRelated Research Data
The Public Health Impact of the So-Called “Fluad Effect” on the 2014/2015 Influenza Vaccination Campaign in Italy: Ethical Implications for Health-Care Workers and Health Communication Practitioners
Source:
Springer International Publishing
The “Fluad Case” in Italy: Could it have been dealt differently?
Source:
Informa UK Limited
Challenges in implementing yearly enhanced safety surveillance of influenza vaccination in Europe: lessons learned and future perspectives.
Source:
Informa UK Limited
Longitudinal data analysis using generalized linear models
Source:
Oxford University Press (OUP)
Enhanced Safety Surveillance of GSK’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany, and Spain for the 2018/19 Season: Interim Analysis
Source:
Springer Science and Business Media LLC
RCGP Research and Surveillance Centre: 50 years’ surveillance of influenza, infections, and respiratory conditions
Source:
Royal College of General Practitioners
Web-based intensive monitoring of adverse events following influenza vaccination in general practice.
Source:
Elsevier BV
THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL
Source:
Oxford University Press (OUP)
Linking provided by
